The tumour suppressor PALB2 stimulates error-free DNA repair by homologous recombination (HR). It also associates with actively transcribed chromatin and protects these regions from DNA damage. However, the mechanism by which PALB2 switches between these functions remains enigmatic. Here, we show that the PALB2 chromatin association motif (ChAM), which directly binds to nucleosomes, is targeted by acetylation at a cluster of seven lysine residues (the '7K-patch'). ChAM acetylation within the 7K-patch enhances its nucleosome binding, while limiting its non-specific DNA binding. Importantly, ChAM acetylation is rapidly removed upon DNA damage, resulting in reduced PALB2 chromatin association and increased mobility within the nucleus. The 7K-null mutation confers HR deficiency, including increased sensitivity to the anti-cancer drug Olaparib. Thus, our findings reveal a unique mechanism mediated by acetylation of non-histone protein, which regulates the chromatin interaction of PALB2 to orchestrate efficient DNA repair in human cells and hence promotes genome stability.
Introduction
PALB2, the partner and localizer of the breast cancer susceptibility 2 protein (BRCA2) 1 , plays essential roles in the maintenance of cellular homeostasis and disease prevention in humans. Biallelic mutations in PALB2 are known to cause Fanconi anaemia (FA), a rare genetic disorder characterized by bone marrow failure, developmental abnormalities, and increased incidence of childhood cancers 2, 3 . Hereditary monoallelic PALB2 mutations are also associated with predisposition to breast and pancreatic cancer 4, 5 , similarly to inherited BRCA1 and BRCA2 mutations 6 . At the molecular level, PALB2, BRCA1, and BRCA2 function together to promote the repair of highly genotoxic double-strand DNA breaks (DSBs) by homologous recombination (HR). HR is an error-free repair mechanism that uses the replicated sister chromatid as a repair template and is primarily catalyzed by the RAD51 recombinase. Current models propose that PALB2 is recruited to sites of DNA damage in a manner dependent on BRCA1 7 . Subsequently, a fraction of BRCA2 in complex with RAD51 is mobilized and, in this way, promotes homology search on the sister chromatid, strand invasion, and DNA repair synthesis 1, 7 . Importantly, we have previously found that PALB2 functions beyond DSB repair. In undamaged cells, PALB2 constitutively associates with actively transcribed genes and protects these regions from DNA damage arising from replication stress, such as collisions between the transcription and replication machineries 8 . However, while the role of PALB2 in genome stability control is well established, the regulatory mechanisms by which PALB2 promotes HR repair remain elusive.
The ability of PALB2 to associate with chromatin is central to its function. PALB2 associates with active genes through its interaction with MORF-related gene on chromosome 15 (MRG15), a chromodomain-containing protein and reader of histone H3 trimethylated at lysine 36 (H3K36me3) that marks active transcription [8] [9] [10] . Additionally, the chromatin-association motif (ChAM), an evolutionarily highly conserved domain uniquely found in PALB2 orthologues, mediates direct interaction with nucleosomes 11 .
ChAM is required for the efficient repair of DNA damage induced by the DNA crosslinking agent mitomycin C (MMC) 8, 11 or the topoisomerase inhibitor camptothecin (CPT) 8 , as well as for optimal DNA stress signaling 12 . Intriguingly, previous observations suggest that PALB2 chromatin association changes dynamically upon DNA damage. Indeed, chromatin immunoprecipitation coupled with quantitative real-time PCR (ChIP-qPCR) revealed that CPT treatment reduced PALB2 association with genic regions, which was concurrent with decreased PALB2-MRG15 interaction and increased PALB2-RAD51 binding 8 . Nonetheless, the molecular mechanisms governing such a dynamic chromatin association remain unknown.
The DNA damage response (DDR) is orchestrated by numerous reversible posttranslational modifications (PTMs), including phosphorylation, ubiquitylation, SUMOylation, poly(ADP-ribosyl)ation, methylation, and acetylation (reviewed in 13 ). For example, damage-induced PALB2 phosphorylation at residues S59, S177, and S376, mediated by the DNA damage signalling kinases ATM and ATR, facilitates PALB2-BRCA1 interaction and RAD51 foci formation in the DDR [14] [15] [16] . Conversely, G1-specific PALB2 ubiquitylation by the E3 ligase KEAP1-CUL3-RBX1 at residue K25 suppresses its interaction with BRCA1, and hence restricts HR 17 . We recently identified PALB2 as a substrate of the lysine acetyltransferases (KATs) GCN5/KAT2A and PCAF/KAT2B 18 , two well-known transcriptional regulators that also function in DNA replication and DNA repair (reviewed in 19 ). However, it is currently unknown whether lysine acetylation plays a role in regulating PALB2 functions.
The function of KAT2 is closely linked to metabolic signalling since their enzymatic activity requires the metabolite acetyl coenzyme A (acetyl-CoA) as a cofactor 20 , suggesting that they may fine-tune cellular processes through target acetylation in accordance with the metabolic status of the cell 21 . Importantly, cancer cells are characterised by both reprogrammed metabolism and elevated genome instability. Nutrient limitations in the tumour microenvironment can increase genome instability 22 , which is associated with malignant transformation and resistance to cancer therapy. It is therefore conceivable that cancer cell metabolism alters the landscape of post-translational modification of proteins involved in genome stability maintenance, thus exacerbating genome instability.
Based on this premise, the study of KAT-mediated lysine acetylation in genome stability maintenance could reveal molecular mechanisms by which reprogrammed metabolism enhances genome instability in cancer cells and contributes to malignant transformation.
In this study, we investigated the role of KAT2A/B-mediated lysine acetylation in the regulation of PALB2 chromatin association. We showed that KAT2A/B could acetylate a cluster of seven lysine residues (the 7K-patch) within PALB2 ChAM, which enhanced its association with chromatin. Furthermore, DNA damage-induced deacetylation led to chromatin dissociation and increased PALB2 mobility. At the cellular level, lysine to glutamine (Q) substitutions in the 7K-patch resulted in the inability of PALB2 to associate with either nucleosomes or DNA, and severely compromised its function in the DDR. Our findings highlight the importance of acetylation-regulated PALB2 chromatin association in genome stability maintenance.
Materials and Methods

Cell culture and cell lines
All cells were grown at 37°C in an incubator with a humidified atmosphere with 5% CO2.
HEK293T cells were grown in Dulbecco's Modified Eagle's Medium (DMEM, Sigma) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 0.1 mg/mL streptomycin. U2OS Flp-In T-REx P2shRNA cells 8 , carrying a doxycycline-inducible shRNA targeting the endogenous PALB2 3' UTR, were used to generate stable isogenic cell lines with constitutive expression of N3xFLAG-PALB2 variants. U2OS Flp-In T-REx P2shRNA cells were co-transfected with pOG44 and pcDNA5/FRT GW/N3×FLAG-PALB2 (7Q or 7R), and recombinant stable cell lines were selected in DMEM supplemented with 10% FBS, 100 U/mL penicillin, 0.1 mg/mL streptomycin, 10 µg/mL blasticidin, 200 μg/mL hygromycin B (100 µg/mL to maintain the cell lines), and 1 µg/mL puromycin. Stable U2OS Flp-In T-REx P2shRNA cells lines carrying the empty pcDNA5/FRT GW/N3×FLAG vector or the pcDNA5/FRT GW/N3×FLAG-PALB2 WT vector have been previously described 8 . EUFA1341 cells were transfected with pCEP4-FLAG PALB2 WT or 7R, and stable cell lines expressing FLAG-PALB2 constructs were isolated following hygromycin selection (300 µg/mL) and later maintained using 150 µg/mL hygromycin.
Antibodies
The primary antibodies used (with their respective working dilutions) were against: FLAG (Sigma F1804, mouse, WB: 1/1000), pan-acetyl lysine (AcK) (Cell Signaling Technology (CST) 9441S, rabbit, WB: 1/1000), PALB2 (Bethyl A301-246A, rabbit, WB: 1/500), BRCA2 (Millipore OP95, mouse, WB: 1/1000), RAD51 (Yata et al. 23 
DNA damage and cell treatment
For ionising radiation-induced DNA damage, cells were exposed to a 4 Gy dose of γ-rays using a 137 Cs source, delivering a dose rate of 1.68 Gy/min (Gravatom). For treatment with either MMC (Sigma M0503) or Olaparib (Enzo Life Sciences LKT-O4402), cells were incubated for 2 h at 37°C with either 1 mM MMC or 2.5 μM Olaparib. DMSO was used as negative vehicle control for Olaparib treatment. KDAC inhibition was performed by treating cells with 5 mM sodium butyrate (NaB, Sigma 303410), 5 μM trichostatin (TSA, Sigma T8552) and 0.5 mM nicotinamide (NaM) for 2 h at 37°C.
siRNA treatment
For KAT2A/GCN5 and KAT2B/PCAF knockdowns, U2OS cells at 30% confluence were transfected using DharmaFECT (Dharmacon) according to the manufacturer's instructions, with 50 pmol each of ON-Targetplus SMARTpools siRNAs targeting KAT2A (Dharmacon L-009722-02-0005) and KAT2B (Dharmacon L-005055-00-0005) in serumfree DMEM. As a negative control, 100 pmol of ON-TARGETplus non-targeting pool siRNAs (Dharmacon D001810-10-05) were used. The serum-free medium was replaced with DMEM supplemented with 10% FBS 24 h after transfection, and the cells were collected by trypsinisation, 72 h after transfection.
Fluorescence recovery after photobleaching (FRAP)
For FRAP experiments, cells were plated into CELLview cell culture dishes (Greiner Bio-One) and analysed in phenol red-free Leibovitz's L15 medium (Gibco). FRAP experiments were performed on a spinning-disk confocal microscope (Ultra-View Vox, Perkin Elmer) mounted on an IX81 Olympus microscope with an Olympus 60x 1.4 oil PlanApo objective, in a controlled chamber at 37°C and 5% CO2 (TOKAI HIT stage top incubator). The fluorescence signal was detected using an EMCCD camera (ImagEM, Hamamatsu C9100-13). Cells were bleached in the GFP channel at maximum laser power with a single pulse for 20 ms, within a square region of interest of 5 µm 2 . After bleaching, GFP fluorescence recovery was monitored within the bleached area every second for 40 s. FRAP parameters were controlled using Volocity software 6.0 (QuorumTechnologies). FRAP data were fitted and normalised using the FRAP plugins in Image J/Fiji 24 . From the FRAP curve fitting, half-time recovery time values after photobleaching (t1/2) were extracted and plotted in Prism 7.02 in which statistical analyses were performed. Normalised fluorescence intensity after photobleaching was calculated by dividing the fluorescence intensity at the bleached area by the whole cellular fluorescence intensity.
Protein purification
Flag-KAT2A, Flag-KAT2A catalytic mutant, and Flag-KAT2B proteins were purified as described in Fournier et al. 18 . GST-PALB2 full-length and fragments were purified from 1 L of ArcticExpress cells (Agilent Technologies), grown at 37°C in LB broth medium containing 50 µg/mL ampicillin and 25 µg/mL gentamycin. Protein expression was induced in the presence of 0.1 mM IPTG for 24 h at 13°C. Cells we collected by centrifugation for 15 min at 1,400 × g at 4°C and washed with ice-cold phosphate-buffered saline (PBS). GFP-ChAM were pull-down using 15 µL GFP-Trap Agarose, pre-washed three times with ice-cold NETN250 buffer and blocked for 3 h at 4°C on a rotating wheel with 500 µL ice-cold NETN250 buffer supplemented with 2 mg/mL bovine serum albumin (BSA, Sigma).
After 3 h protein binding at 4 °C on a rotating wheel, the GFP-Trap beads were collected by centrifugation for 5 min at 1,000 × g, 4°C and washed four times with ice-cold NETN250 buffer. For the nucleosome pull-down assays, GFP-ChAM variants were affinity-purified from HEK293T cells (3 × 10 7 cells) following transient expression. After collecting cells by centrifugation for 5 min at 500 × g, 4°C, the cell pellet was washed twice with ice-cold PBS and resuspended in ice-cold NETN150 buffer supplemented with 10 mM benzamidine hydrochloride (Benz-HCl) and PIC. After 30 min incubation on ice, the chromatin was pelleted by centrifugation for 5 min at 500 × g, 4°C, and the supernatant was collected as NETN150 soluble fraction and centrifuged for 30 min at 16,100 × g, 4°C to remove cell debris and insoluble material. For each sample, 10 µL of GFP-Trap Agarose were washed three times with 500 µL ice-cold NETN150 buffer. NETN150 soluble proteins (2.5 mg) in a total volume of 1 mL ice-cold NETN150 buffer were incubated with the GFP-Trap beads to perform a GFP pull-down. After 2 h protein binding at 4°C on a rotating wheel, the GFP-Trap beads were collected by centrifugation for 5 min at 500 × g, 4°C and washed four times with ice-cold NETN150 buffer. Human nucleosomes were partially purified from HEK293T cells (4 × 10 7 cells), collected by centrifugation for 5 min at 500 × g, 4°C,
washed twice with ice-cold PBS and lysed in ice-cold NETN150 buffer supplemented with 10 mM Benz-HCl and PIC). After 30 min of incubation on ice, the chromatin was pelleted by centrifugation for 5 min at 500 × g, 4°C, washed once with ice-cold NETN150 buffer and digested for 12 min at 37 °C with 50 gel units of micrococcal nuclease (NEB) per milligram of DNA in NETN150 buffer containing 5 mM CaCl2, using 200 µL buffer per mg of DNA. The reaction was stopped with 5 mM EGTA and the nucleosomes suspension cleared by centrifugation for 30 min at 16,100 × g, 4°C.
Acetyltransferase assays
Radioactive 14 C-acetyltransferase assays on recombinant proteins were performed by incubating purified GST-PALB2 (full length and fragments) or purified RAD51 with purified FLAG-KAT2B in the presence of 14 C-labeled acetyl-CoA. The reaction buffer contained 50 mM Tris-HCl pH 8.0, 10% glycerol, 100 mM EDTA, 50 mM KCl, 0.1 M sodium butyrate, protease inhibitor cocktail, and 5 mM DTT. Reactions were incubated for 1 h at 30°C, stopped by addition of Laemmli buffer containing 10%-mercaptoethanol, boiled for 5 min, resolved by SDS-PAGE, and stained using Coomassie blue to reveal overall protein distribution. The acrylamide gel containing proteins was then dried and exposed to phosphorimager to reveal 14 C-labeled proteins. Non-radioactive acetyltransferase assays were performed as described above using cold acetyl-CoA instead. After 1 h incubation at 30°C, the reactions were stopped by addition of Laemmli buffer containing 10 mM DTT, boiled for 5 min, resolved by SDS-PAGE, and analysed by western blot using anti-acetyl lysine antibodies, after Ponceau S staining of the membrane to reveal overall protein distribution. Acetyltransferase assays performed for mass spectrometry analyses were performed as described in Fournier et al. 18 .
Nucleosome pull-down assay
Nucleosome pull-down assays were performed by mixing in NETN150 buffer supplemented with 2 mg/mL BSA, 250 µg of partially purified nucleosomes and GFP-ChAM variants immobilised on GFP Trap beads, followed by 30 min incubation at RT, then 1.5 h incubation at 4 °C, on a rotating wheel. GFP-Trap beads were further washed four times with NETN150 buffer, and samples were analysed by SDS-PAGE and western blot.
DNA binding assays
For ChAM peptides binding to DNA, proteins or peptides were incubated in NDTN150 buffer (50 mM Tris HCl pH 7.5, 150 mM NaCl, 0.5% NP-40 and 2 mM DTT) in the presence of 300 ng pBluescript plasmid DNA for 1 h at RT. Reactions were loaded onto a 1% agarose Tris-Acetate-EDTA (TAE) gel and run at 100 V for 60 min. The gel was stained for 1 h at RT using 0.5 µg/mL ethidium bromide in Tris-Borate-EDTA (TBE) buffer. Binding of ChAM peptide to histone H3 was performed by incubating for 1 h at 4°C biotinylated ChAM peptides and histone H3 protein in NDTN250 buffer (50 mM Tris HCl pH 7.5, 250 mM NaCl, 0.5% NP-40, and 2 mM DTT) supplemented with 5 mg/mL BSA. Dynabeads MyOne T1 blocked with BSA in NDTN250 buffer were added to the peptide-Histone H3 mixture and incubated for 1 h at 4°C. Immobilised complexes were washed three times with NDTN250 buffer and proteins were visualised by western blotting using the indicated antibodies.
Immunofluorescence microscopy
For γ-H2AX foci analysis, cells were grown on coverslips and washed with PBS before preextraction with 0.1% Triton in PBS for 30 s at RT. Cells were then fixed twice with 4% PFA in PBS, first for 10 min on ice and then for 10 min at RT. After permeabilisation in 0.5% Triton X-100 in PBS for 10 min at RT, cells were blocked with 5% BSA in PBS-0.1% Tween 20 solution and incubated with anti-γ-H2AX primary antibodies (see antibodies section) for 3 h at RT. After washing with PBS-0.1% Tween 20 for 5 min at RT, cells were incubated with secondary antibodies coupled with a fluorophore, washed with PBS-0.1% Tween 20 for 5 min at RT, and mounted on slides using a DAPI-containing solution. For RAD51 foci analysis, cells were grown on coverslips and washed twice with PBS before fixation with 4% PFA in PBS for 15 min at RT. After washing twice with PBS, cells were permeabilised with PBS-0.5% Triton X-100 for 5 min at RT and blocked with 3% BSA in PBS-0.1% Triton X-100 before incubation with anti-RAD51 primary antibodies (see antibodies section) for 2 h at RT. After washing three times with PBS-0.5% Tween 20, cells were incubated with secondary antibodies coupled with a fluorophore, washed three times with PBS-0.5% Tween 20 and mounted on slides using a DAPI-containing solution.
Cells were analysed on a spinning-disk confocal microscope (Ultra-View Vox, Perkin Elmer) mounted on an IX81 Olympus microscope, with a 40x 1.3 oil UPlan FL objective.
The fluorescence signal was detected using an EMCCD camera (ImagEM, Hamamatsu C9100-13). Images were processed in Image J (https://imagej.nih.gov/ij/) 25 .
Sequence alignment analysis
Sequences of PALB2 orthologues from 12 species were retrieved from the Ensembl 
Results
PALB2 diffusion rate increases upon DNA damage and protein deacetylation
To investigate the spatio-temporal dynamics of PALB2 in the DDR, we used fluorescence recovery after photobleaching (FRAP) in cells stably expressing a PALB2 fusion with FLAG and EGFP (FE-PALB2). We first assessed the diffusion kinetics of FE-PALB2 in cells Together, these results suggested that PALB2 dynamics was increased upon DNA damage and by suppressing lysine acetylation events.
KAT2A/B acetylates PALB2 within its ChAM, which is deacetylated upon DNA damage
To address the molecular mechanism by which lysine acetylation regulates the dynamics of PALB2, we next mapped the residues modified by KAT2A/B. Our previous shotgun mass spectrometry (MS) analysis of the endogenous acetylome revealed that lysine residues within the central region of PALB2 were frequently acetylated in a KAT2A/Bdependent manner ( Fig. 2A ). To verify that KAT2A/B could directly acetylate PALB2, we performed in vitro acetylation assays using either recombinant full-length PALB2 or a series of PALB2 fragments ( Fig. 2A) with purified KAT2A or KAT2B, and detected acetylation by 14 C-autoradiography ( Fig. 2B ) or western blot (WB) against acetylated lysine (pan-AcK) ( Supplementary Fig. 2 ). Lysine acetylation of full-length PALB2 and fragment 2, which encompasses the central region of PALB2 (residues 295-610), was clearly visible following in vitro acetylation with KAT2A ( Supplementary Fig. 2B ) or KAT2B ( Fig. 2B and Supplementary Fig. 2A ), but not with a catalytically inactive mutant of KAT2A ( Supplementary Fig. 2B ).
Our tandem MS analysis of in vitro acetylated PALB2 identified acetylation events enriched at lysine residues within PALB2 ChAM ( Fig. 2A, C) . A similar acetylation pattern was detectable in an extended ChAM fragment (PALB2 residues 353-499, corresponding to fragment #5 in Fig. 3A ), which was expressed in HEK293T cells and purified from chromatin-enriched fraction (Fig. 2D ). Acetylated residues within ChAM were mapped to a cluster of seven lysine residues (denominated the 7K-patch), composed of K436, K437, K438, K441, K443, K445, and K449. All MS/MS spectra for acetylated PALB2 peptides are provided in the supplementary material. Importantly, ChAM was rapidly deacetylated upon IR treatment (within 15 min) and remained deacetylated for at least 2 h ( Fig. 2E ).
Collectively, our results reveal a changing pattern of PALB2 acetylation in human cells whereby the ChAM is highly acetylated in normally growing cells but rapidly deacetylated upon DNA damage.
ChAM acetylation regulates PALB2 chromatin association
The identification of lysine acetylation within ChAM was particularly interesting since acetylation-mediated regulation of ChAM function could explain the changes in PALB2 diffusion rate detectable by FRAP ( Fig. 1) , as well as the damage-induced PALB2 release from actively transcribed genes shown previously using ChIP-qPCR 8 . Encouraged by these observations, we next examined the impact of the 7K-patch on ChAM chromatin association. Analysis of the chromatin fraction of HEK293T cells expressing GFP fusions of various ChAM truncations revealed that the region containing the 7K-patch was essential for its chromatin enrichment (Fig. 3A, B ). To eliminate the possibility that reduced chromatin enrichment resulted from mislocalisation of the 7K-patch-deleted variants to the cytoplasm, we assessed in vitro the direct interaction between the same fragments purified from the soluble fraction of HEK293T cells and separately prepared human nucleosomes. The pull-down assay showed that, indeed, deletion of the 7K-patch led to impaired ChAM interaction with nucleosomes ( Fig. 3C) .
To assess the role of acetylation within the 7K-patch in ChAM nucleosome binding, we next used synthetic ChAM peptides (PALB2 residues 395-450) acetylated at evolutionarily conserved lysine residues within the 7K-patch, K436, K437, and K438 ( Fig. 2A, D) . Our in vitro nucleosome binding assays revealed that ChAM binding to nucleosomes was modestly enhanced by acetylation at K436, K437, or K438 compared to the non-acetylated ChAM peptide (Fig. 3D) . Remarkably, we found that, in the presence of excess salmon sperm DNA, non-acetylated ChAM lost its ability to bind nucleosomes, while acetylated ChAM maintained its association. The effect was most prominent with K438 acetylation, which was detected in our previous MS study of the endogenous HeLa KAT2A/B-acetylome. We surmise that non-specific electrostatic interactions between DNA and the non-acetylated lysine residues (K441, K443, K445, and K449) in the vicinity of the acetylated residues contributes to overall binding but is titrated out in the presence of excess salmon sperm DNA. These observations suggest that acetylated ChAM residues mediate specific interaction with the histone core.
Considering the likely interaction between the positively charged 7K-patch and negatively charged DNA, we next assessed the impact of acetylation at K436, K437, and K438 on ChAM binding to DNA. As anticipated, lysine acetylation, which neutralises the positive charge on the lysine side chain, abolished ChAM interaction with DNA ( Fig. 3E, F) .
These results suggested that the 7K-patch plays an important role in regulating the mode of ChAM chromatin association: acetylation within this region enhanced its unique nucleosome binding properties while reducing its non-specific affinity for DNA. Notably, a PALB2 variant with an internal deletion of the ChAM domain, which abolishes PALB2 chromatin association 11 , showed a significant increase in PALB2 diffusion rate, as defined by reduced FRAP t1/2 ( Supplementary Fig. 3 ). This observation suggested that increased PALB2 mobility reflected the chromatin-free fraction of PALB2. Altogether, these observations support the notion that ChAM acetylation facilitates PALB2 chromatin association and restricts its mobility.
The ChAM 7K-patch regulates PALB2 chromatin association
We next aimed to assess the physiological impact of 7K-patch acetylation in vivo. With this in mind, we first examined the biochemical properties of ChAM variants in which lysine residues within the 7K-patch were substituted to glutamine. K to Q substitutions neutralise the charge and are hence widely used to mimic lysine acetylation ( Supplementary Fig. 4A ). We generated recombinant GST-fusions of ChAM WT and mutants harboring Q substitutions at all seven lysine residues (7Q), three conserved lysine residues, K436, K437, and K438 (3Q4K), or the four remaining lysine residues, K441, K443, K445, and K449 (3K4Q) within the 7K-patch (Fig. 4A, B ). Unexpectedly, in vitro nucleosome binding assays showed that all variants with Q substitutions abolished ChAM interaction with nucleosomes ( Fig. 4C ). This observation appeared to be at odds with our findings that ChAM acetylation enhanced nucleosome binding ( Fig. 3D ) and that PALB2 mobility increased upon KAT2A/B inhibition or induction of DNA damage, which coincided with reduced ChAM acetylation (Fig. 1D-H and Fig. 2E ). Glutamine has a shorter side chain than a bona fide acetylated lysine ( Supplementary Fig. 4A ); hence, we reasoned that, while mimicking the charge neutralisation of lysine acetylation, it may hinder nucleosome binding. These observations, therefore, suggest that the interpretation of data resulting from K to Q substitutions as acetyl-mimetic may be misleading in certain contexts. As anticipated from the change in electrostatic charge, all ChAM variants with K/Q substitutions exhibited an impaired association with DNA ( Fig. 4D ).
Our biochemical analyses demonstrated that 7Q substitution hindered ChAM ability to associate with both nucleosomes and DNA. Hence, hereafter, we used this variant as a PALB2 ChAM 7K null-mutant and examined how the association of PALB2 with nucleosomes and DNA impacted its dynamics in vivo. Along with the 7Q PALB2 variant, we generated a PALB2 variant in which ChAM 7K residues were substituted to arginine (R). Arginine substitution maintains the overall positive charge but cannot accept acetylation. Cell lines stably expressing GFP-fusions of full-length PALB2 7Q or 7R variants were established, and their dynamics were assessed using FRAP. We found that similarly to PALB2 ChAM deletion mutant ( Supplementary Fig. 3 ), PALB2 7Q mutant exhibited increased diffusion kinetics compared to PALB2 wild-type (WT) and 7R (Fig. 4E,   F ). In line with this observation, the PALB2 7Q mutant showed significantly reduced enrichment in the chromatin fraction of cells compared to PALB2 WT and 7R ( Supplementary Fig. 4B, C) . The increased mobility of PALB2 7Q is thus consistent with its impaired chromatin association, potentially reflecting free diffusion in the nucleus.
Intriguingly, PALB2 recruitment to DNA damage sites was not hindered by 7Q and 7R mutations, as shown by laser micro-irradiation experiments ( Supplementary Fig. 4D, E) .
Collectively, these observations suggest that lysine residues within the ChAM 7K-patch are essential for regulating PALB2 chromatin association and mobility within cells, but dispensable for promoting its recruitment to sites of DNA damage.
PALB2 ChAM 7K-patch is required to maintain genome stability
To assess the physiological role of the ChAM 7K-patch in the regulation of PALB2 function in the DDR, we established U2OS cell lines in which endogenous PALB2 can be downregulated by a doxycycline-inducible short hairpin RNA (U2OS-shPALB2). These include stable lines harbouring an empty vector (EV), as a negative control, or an expression vector for FLAG-tagged full-length PALB2 WT, 7Q or 7R variants. WB analysis confirmed that all cell lines exhibit equivalent levels of FLAG-PALB2 protein expression and efficient depletion of endogenous PALB2 upon doxycycline exposure (Fig. 5A) .
The best-characterised function of PALB2 in the DDR is to support RAD51 foci formation and hence facilitate HR repair of DSBs. Endogenous PALB2 depletion in EV cells abolished RAD51 foci formation in both undamaged and DNA damage conditions ( Supplementary Fig. 5A ). Importantly, damage-induced RAD51 foci formation was efficiently restored in U2OS-shPALB2 cells expressing PALB2 WT or 7R but remained severely impaired in those expressing PALB2 7Q (Fig. 5B, C) . Further, U2OS-shPALB2 cells expressing PALB2 7Q exhibited a higher level of sensitivity to Olaparib than their PALB2 WT or 7R expressing counterparts (Fig. 5D) . Given that increased sensitivity to PARP inhibition is a hallmark of HR deficiency, this finding suggests that the 7Q substitutions conferred HR defects. Notably, neither PALB2 7R nor 7Q presented defects in their interactions with BRCA2 or RAD51 ( Supplementary Fig. 5B ). Collectively, these observations support the notion that defective DDR in U2OS-shPALB2 cells expressing PALB2 7Q is caused by its inability to associate with chromatin.
Discussion
In this study, we have demonstrated that reversible PALB2 acetylation controls its mode of chromatin association, which is essential during the DDR: the 7K-patch in the Cterminal part of ChAM was acetylated by KAT2A/B in undamaged cells but deacetylated upon DNA damage. Crucially, ChAM acetylation enhances PALB2 binding to nucleosomes and limits non-specific interactions with DNA. DNA damage, however, triggers PALB2 deacetylation and increases the overall mobility of PALB2. The PALB2 7Q variant, which fails to associate with either nucleosomes or DNA, was markedly unable to support HR, despite its intact interactions with BRCA2 and RAD51 and normal recruitment to sites of DNA damage. Considering all our findings collectively, we propose the model shown in 8 , which releases PALB2 from chromatin. In this way, PALB2 may become available to form functional HR complexes with BRCA1, which is otherwise less stably associated with PALB2 8 . Following the recruitment of the entire HR complex to sites of DNA damage, deacetylated ChAM binding to exposed naked DNA may allow appropriate engagement of this complex with damaged DNA, and hence, promote RAD51 loading and HR repair.
The increase in PALB2 dynamics during the DDR shown in this study is reminiscent of previous reports revealing increased RAD51 mobility upon replication stress 26, 27 . Yu et al. have shown that a fraction of RAD51, which is in complex with BRCA2, is immobile in unchallenged cells, but becomes mobile upon hydroxyurea-induced replicative stress 26 . Notably, their data suggested that such increased RAD51 mobility was unlikely to be a consequence of altered interaction with BRCA2 since no change in RAD51-BRCA2 interaction was detectable upon replicative stress. Similarly, Jeyasekharan et al. have reported increased BRCA2 mobility upon IR-induced DNA damage, which was induced in a manner dependent on the DNA damage signalling kinases ATM and ATR and coincided with active HR events 28 . In light of previous observations that BRCA2 and PALB2 form a stable complex (B2P2 complex) together with a fraction of RAD51, and that their interaction is important for HR repair, we propose that the B2P2 complex and associated RAD51 are mobilised together upon genotoxic stress.
The dynamic exchange of HR factors appears to extend beyond damaged chromatin, and our observations raise a fundamental question: what could be the benefit of such a phenomenon in the DDR? One possibility is that the B2P2 complex needs to relocate from undamaged actively transcribed chromatin to sites of DNA damage, a process that likely requires a release of the complex from chromatin 8 . Cells may derive an advantage by retaining the B2P2 complex readily available and in close proximity to regions highly vulnerable to DNA damage, such that it can be promptly recruited when DNA damage arises, for instance upon replication-transcription collisions. Notably, however, there is an indication that the increase in PALB2 mobility is long-lived; we observed that PALB2 remained less acetylated after DNA damage, and thus in a highly mobile form, for at least two hours after induction of DNA damage. Hence, it is tempting to speculate that increased PALB2 mobility may assist DNA repair over a broader range of time and space. MS-based protein copy number estimates showed that endogenous PALB2 and BRCA2 are stoichiometric, but are significantly less abundant than RAD51 29, 30 .
It is therefore conceivable that the B2P2 complex acts as a carrier to continually recruit new RAD51 molecules from the free excess pool across the nucleus, following the loading of associated RAD51, throughout the HR process.
The mechanisms that regulate the localisation of HR factors remain incompletely understood but undoubtedly involve PTMs. We propose that variable modes of PTMmediated chromatin association synergistically govern the recruitment of repair factors to defined regions of chromatin. In unchallenged cells, PALB2 is enriched at actively transcribed chromatin through ChAM acetylation and H3K36me3-mediated MRG15 interaction, while maintaining transient chromatin interaction without stable engagement. This mode of association may allow a severance mechanism, in which PALB2 continuously monitors the presence of DNA damage across these regions. Upon DNA damage, PALB2 may shift to a distinct mode of chromatin association, which allows its recruitment to sites of DNA damage through interaction with BRCA1, fulfilling its function in promoting HR repair. Intriguingly, cells expressing the non-acetylable PALB2 7R variant exhibited no detectable HR defects. While this observation is compatible with our finding that ChAM is deacetylated upon DNA damage, our preliminary results also suggest that this variant may have limited capacity in the surveillance mechanism in undamaged cells. Indeed, cells expressing PALB2 7R exhibited an increase in the basal level of γ−H2AX compared to those expressing PALB2 WT (data not shown), highlighting the importance of PALB2 acetylation in unperturbed cells. Our work also suggests that caution should be exercised in the use of K to Q substitutions for functional studies of lysine acetylation. We anticipate that robust in vivo assessment of acetylation events may require the development of a chemically modifiable residue, which exhibits improved similarity to acetylated lysine in a reversible manner.
More broadly, lysine acetylation is known to control biological processes (e.g., gene transcription 31 ) based on the metabolic status of the cell. Therefore, a better appreciation of the role of lysine acetylation in the DDR could expand the scope of studies aiming to understand how reprogrammed metabolism could increase genome instability in cancer cells 22 . Since PTMs are essential to ensure the maintenance of physiological homeostasis and metabolites are necessary cofactors for the deposition of these PTMs, we envision that reprogrammed metabolism in cancer cells could alter the PTM landscape for proteins involved in the DDR and, hence, contribute to genome instability. In this study, we established that reversible PALB2 acetylation regulates its mobility and function in the DDR. Considering that glucose concentration in the growth medium can influence the level of protein acetylation in cells 31 , it will be important to understand whether PALB2 function could be affected by cellular metabolic status. Strikingly, our preliminary results demonstrated that glucose concentration in the growth media does indeed affect PALB2 mobility (data not shown). This observation supports the notion that in tumour cells with reprogrammed metabolism, protein properties (e.g., chromatin association) could be detrimentally altered. Future studies will assess whether aberrant PALB2 lysine acetylation may be detected in cancer tissues and whether this is modulated by KDAC or bromodomain inhibitors, currently in clinical trials for cancer therapy, or by alteration of glucose metabolic pathways. Furthermore, deciphering the metabolic regulation of the DDR and DNA repair could highlight additional cellular pathways that might be targeted for cancer therapy, possibly in combination with existing therapies that otherwise may give rise to resistance. 
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